Osteoporosis is a common disease characterised by a systemic impairment of bone mass
and microarchitecture that results in fragility fractures. With an ageing population, the medical …

… osteoporosis, but also have opened doors of opportunity to improvements in the effective
treatment. However, the high cost of new … early diagnosis of osteoporosis and understanding of …

… In conclusion, odanacatib is a potential new antiresorptive treatment of osteoporosis with
an anti-fracture efficacy comparable to current treatments. The drug still awaits approval by the …

… Osteoporosis is a disease characterized by low bone mass … One of the major challenges in
the management of osteoporosis lies … Furthermore, osteoporosis often remains undiagnosed …

… used for treatment of osteoporosis in postmenopausal women. … options for the treatment of
osteoporosis, only alendronate, … very elderly women with osteoporosis, oral bisphosphonates …

… Osteoporosis is a bone metabolic disease characterized by a compromised skeletal fragility,
… is to describe the new therapeutic horizons for the cure of postmenopausal osteoporosis. …

… The prevalence of osteoporosis in the world was reported to be 18.3%, and the economic
burden of osteoporosis-related fracture reaches approximately $17.9 and £4 billion per annum …

… of the risk factors for osteoporosis and to keep abreast of new treatments available to women…
a safe environment from falls for women with osteoporosis, weight-bearing exercise to avoid …

… the new horizons in bone health and osteoporosis … , the skeletal structure and nature of
osteoporosis, as well as the … challenges and limitations of osteoporosis diagnosis, best practice …

… vertebral osteoporosis, the frail, those who fall and patients with secondary osteoporosis. …
important clinical feature is an association of osteoporosis with so-called ‘fragility fractures’. …